AEGI Insights
Methods, market signals and evidence-oriented guidance for financial institutions deciding whether one proposed change deserves the next controlled stage.
Bring One WorkflowKnowledge surface
AEGI Insights is designed to grow with the research programme. Current articles cover controlled evaluation, fraud and risk workflows, assurance and Southeast Asian regulatory practice; future market research can use the same canonical publishing system without creating a second content silo.
A banking AI system can produce useful intelligence without owning the authority to act. This is the control principle behind AEGI Shield's separation of recommendation, policy and evidence.
Why putting credit and fraud scores on one screen is not the same as creating a provenance-preserving Shared Risk Context for a controlled banking workflow.
AEGI Shield is not a replacement fraud detector, credit model or case-management system. This article explains the layer it occupies and the decision problem it is designed to solve.
A public-safe explanation of AEGI Shield: where it fits in a bank stack, what problem it solves, how controlled evaluation works, what evidence exists, and what remains under bank authority.
How to compare one proposed AI or risk-model change against the current baseline using historical evidence, declared operational constraints and an explicit Continue / Refine / Stop decision — without treating the evaluation as production approval.
How to compare a fraud model, signal or prioritisation treatment with the current baseline at the same declared review capacity — so the evaluation reflects what investigators can actually act on.
A practical method for testing one additional fraud signal against the current workflow without replacing the existing fraud engine or granting the candidate production authority.
Why promising AI pilots often stall — and how financial institutions can turn a prototype result into a controlled progression decision without overclaiming production readiness.
How financial institutions can separate retrospective evidence from live, non-customer-impacting observation when deciding whether an AI or risk-model change deserves progression.
